(WSC‚HCl)18 as a condensing agent in the presence of
1-hydroxybenzotriazole (HOBt).
the kinetic studies a surface pressure of 20 mN‚m-1 was
selected. At this value of surface pressure PPL is highly
active and characterized by linear kinetics.
Remaining lipase activity was measured as a function of
the inhibitor molar fraction (R) (Figure 2). Lipase hydrolysis
The racemic 2-hydroxy fatty acid was prepared by
deamination of the corresponding 2-aminohexadecanoic
acid19 using NaNO2 under acidic conditions. The R-hydroxy
amide 7 was converted to the corresponding R-keto amide
820 using pyridinium dichromate (PDC) in acetic acid, which
proved to be an effective agent for the oxidation affording
the desired product in good yield.
The use of the monolayer technique, which is based upon
surface pressure decrease due to the film hydrolysis, is
advantageous for the study of lipase inhibition since with
conventional emulsified systems it is not possible to control
their “interfacial quality”.21 The kinetic studies of the lipase
hydrolysis reactions requires that the lipids used as substrates
form a rather stable monomolecular film at the air/water
interface.22
To determine the film stability and the interfacial properties
of the R-keto amide derivative 8, we have recorded its force/
area curve at the air/water interface. The experiment was
performed in the reservoir compartment of a “zero-order”
trough. Figure 1 gives the surface pressure dependency as a
Figure 2. Effect of increasing concentrations of 8 on the hydrolysis
rate by PPL of 1,2-dicaprin monolayer maintained at a constant
surface pressure of 20 mN‚m-1. The aqueous subphase was
composed of Tris/HCl 10 mM, pH 8, NaCl 100 mM, CaCl2 21
mM, EDTA 1 mM. The kinetics of hydrolysis were recorded during
15-20 min.
rates of 1,2-dicaprin decreased as the molar fraction of the
inhibitor increased. The dotted line corresponds to the surface
dilution phenomena, which reflects the decrease in lipase
activity that would be observed if a nonsubstrate, noninhibitor
compound, i.e., so-called “surface dilutor”, were present in
the monomolecular film. A 50% decrease in lipase activity
was observed when 14.1 ( 3.5% of 1,2-dicaprin had been
substituted by the inhibitor compound 8. Although this value
corresponds to a rather weak inhibition of pancreatic lipase,
Figure 1. Force/area curve of compound 8. The aqueous subphase
was composed of Tris/HCl 10 mM, pH 8, NaCl 100 mM, CaCl2
21 mM, EDTA 1 mM. The continuous compression experiment
was performed in the rectangular reservoir of the “zero order”
trough.23
(15) Kokotos, G.; Padron, J.-M.; Martin, T.; Gibbons, W. A.; Martin,
V. S. J. Org. Chem. 1998, 63, 3741.
(16) Kokotos, G.; Noula, C. J. Org. Chem. 1996, 61, 6994.
(17) Yield 84%; oil; [R]D +3.6 (c 0.5, CHCl3); 1H NMR (200 MHz,
CDCl3) δ 5.4 (m, 2H), 4.6 (br, 1H), 3.7-3.5 (m, 3H), 2.2-1.9 (m, 4H),
1.6-1.4 (m, 11H), 1.3 (m, 6H), 0.9 (t, J ) 7 Hz, 3H); MS (FAB) m/z (%)
308 (12) [M + Na+], 286 (9) [M + H+], 230 (68), 186 (100). Anal. Calcd
for C16H31NO3: C, 67.33; H, 10.95; N, 4.91. Found: C, 67.09; H, 11.24;
N, 4.82. Enantiomeric excess >95% was indicated by 1H NMR and 19F
NMR analysis of the corresponding Mosher ester.
(18) Sheehan, J. C.; Cruickshank, P. A.; Boshart, G. L. J. Org. Chem.
1961, 26, 2525.
(19) Kokotos, G.; Martin, V. S.; Constantinou-Kokotou, V.; Gibbons,
W. A. Amino Acids 1996, 11, 329.
function of the molecular area of a film spread over a
buffered subphase at pH 8.0. The large molecular area of
the film formed by this compound may be attributed to the
presence of the double bond as well as the two alkyl chains.
The inhibition of pancreatic lipase was studied using the
monomolecular film technique22,23 with mixed films of 1,2-
dicaprin containing variable proportions of compound 8. For
(20) Yield 57%; oil; [R]D +3.1 (c 0.5, CHCl3); 1H NMR (200 MHz,
CDCl3) δ 7.1 (d, J ) 8 Hz, 1H), 5.4 (m, 2H), 4.0 (m, 1H), 3.4 (m, 4H), 2.9
(t, J ) 7 Hz, 2H), 2.1-1.9 (m, 4H), 1.8-1.5 (m, 6H), 1.4-1.1 (m, 42H),
0.9 (m, 9H); 13C NMR (200 MHz, CDCl3) δ 199.4, 159.7, 130.9, 128.2,
71.5, 49.0, 36.8, 31.9-22.3, 14.1-14.0; MS (FAB) m/z (%) 579 (24) [M
+ H+], 578 (100) [M+], 352 (12), 225 (18). Anal. Calcd for C37H71NO3:
C, 76.89; H, 12.38; N, 2.42. Found: C, 76.62; H, 12.56; N, 2.34.
(21) Verger, R.; de Haas, G. H. Annu. ReV. Biophys. Bioeng. 1976, 5,
77.
(13) (a) Street, I. P.; Lin, H.-K.; Laliberte, F.; Ghomashchi, F.; Wang,
Z.; Perrier, H.; Tremblay, N. M.; Huang, Z.; Weech, P. K.; Gelb, M. H.
Biochemistry 1993, 32, 5935. (b) Ackermann, E. J.; Conde-Frieboes, K.;
Dennis, E. A. J. Biol. Chem. 1995, 270, 445. (c) Ghomashchi, F.; Loo, R.;
Balsinde, J.; Bartoli, F.; Apitz-Castro, R.; Clark, J. D.; Dennis, E. A.; Gelb,
M. H. Biochim. Biophys. Acta 1999, 1420, 45.
(22) Ransac, S.; Ivanova, M. G.; Verger, R.; Panaiotov, I. Methods
Enzymol. 1997, 286, 263.
(23) Verger, R.; de Haas,G. H. Chem. Phys. Lipids 1973, 10, 127.
(14) Simons, J.-W. F. A.; Cox, R. C.; Egmond, M. R.; Verheij H. M.
Biochemistry 1999, 38, 6346.
Org. Lett., Vol. 2, No. 3, 2000
349